A carregar...
CSF Multianalyte Profile Distinguishes Alzheimer and Parkinson Diseases
The therapeutic imperative for Alzheimer disease (AD) and Parkinson disease (PD) calls for discovery and validation of biomarkers. Increased cerebrospinal fluid (CSF) τ and decreased amyloid (A) β(42) have been validated as biomarkers of AD. In contrast, there is no validated CSF biomarker for PD. W...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2008
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2688655/ https://ncbi.nlm.nih.gov/pubmed/18343778 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1309/W01Y0B808EMEH12L |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|